semaglutide for 10 lbs weight loss Long-term effects of in obesity without diabetes in the SELECT trial Semaglutide Shines as Weight Loss

By offering Semaglutide, we help our patients achieve better health outcomes, supporting them through every step of their treatment journey

And our current thinking about obesity, and one of the components of the disease of obesity, is that some individuals although they all have GLP-1 and these other gut hormones, amylin, glucagon, GIP, that's what they're called that signal, for some reason, is not getting to the brain in ample amounts to tell the individual to feel full, satiated, and stop eating

Main mechanism Inhibits the reuptake of dopamine, norepinephrine, and serotonin in the brain (a triple monoamine reuptake inhibitor, or SNDRI)

Prof Stephen Nicholls, the lead of the Australian arm of the Select trial and the director of the Victorian Heart Institute at Monash University, said while the GLP-1 RAs medications were originally developed as diabetes drugs, the Select study excluding diabetic patients showed a new frontier for the drugs in their own right